Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Jan 13;32(1):15–20. doi: 10.1002/clc.20445

Elevated Serum Cardiac Troponin in Non‐acute Coronary Syndrome

Yeshitila Agzew 1,✉
PMCID: PMC6653306  PMID: 19143000

Abstract

Cardiac troponins (CTn) are the most sensitive and specific biochemical markers of myocardial injury and risk stratification. The assay for troponin T (cTnI) is standardized, and results obtained from different institutions are comparable. This is not the case with troponin I (cTnT), and clinicians should be aware that each institution must analyze and standardize its own results. Elevated cTn levels indicate cardiac injury, but do not define the mechanical injury. The differentiation of cTn elevation caused by coronary events from those not related to an acute coronary syndrome (ACS) is tiresome, at times vexing, and often costly. Elevation of cTn in non‐ACS is a marker of increased cardiac and all‐cause morbidity and mortality. The cause of these elevations may involve serious medical conditions that require meticulous diagnostic evaluation and aggressive therapy. At present, there are no guidelines to treat patients with elevated troponin levels and no coronary disease. The current strategy of treatment of patients with elevated troponin and non‐ACS involves treating the underlying causes. Copyright © 2009 Wiley Periodicals, Inc.

Keywords: acute coronary syndrome, non‐acute coronary syndrome, troponin I, troponin T, non‐acute coronary syndrome troponin elevation

Full Text

The Full Text of this article is available as a PDF (104.1 KB).

References

  • 1. Korff S, Katas HA, Giannitis E: Differential diagnosis of elevated troponin. Heart 2006; 92(7): 987–993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Falahati A, Sharkey SW, Christensen D, McCoy M, Miller EA, et al.: Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction. Am Heart J 1999; 137: 332–337. [DOI] [PubMed] [Google Scholar]
  • 3. Ottani F, Galvani M, Nicolini FA, Ferrino D, Pozzati A, et al.: Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140: 917–927. [DOI] [PubMed] [Google Scholar]
  • 4. Conti CR: Value of “border line” troponin T measurements in patients with chest pain. Clin Cardiol 2006; 25: 139–140 Published online at www.clinical‐cardiology.com. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Braunwald E, Antman E, Beasly JW, Califf RM, Cheitlin MD, et al.: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non‐st‐segment elevation myocardial infarction. Available at: www.acc.org/qualityandscience/clinical/ statement.htm.
  • 6. Higgins JP, Higgins JA: Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med 2003; 26: 133–147. [PubMed] [Google Scholar]
  • 7. Tate JR, Heathcote D, Koerbin G, Thean G, Andriske D, et al.: The harmonization of cardiac troponin I measurement is independent on the source of calibrator. Clin Chim Acta 2002; 324: 13–23. [DOI] [PubMed] [Google Scholar]
  • 8. Jaffe A: Caveat emptor. Am J Med 2003; 115: 241–244. [DOI] [PubMed] [Google Scholar]
  • 9. Giannitis E, Katus HA: 99th percentile and analytical imprecision of troponin and creantinine kinas‐MB mass assays an objective platform for comparison of assay performance. Clin Chem 2003; 49: 1248–1249. [DOI] [PubMed] [Google Scholar]
  • 10. Panteghini M: Acute coronary syndrome: biochemical strategies in the troponin era. Chest 2002; 122: 1428–1435. [DOI] [PubMed] [Google Scholar]
  • 11. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, et al.: Evaluation of imprecision for cardiac troponin assays at low‐range concentrations. Clin Chem 2004; 50: 327–332. [DOI] [PubMed] [Google Scholar]
  • 12. Katwa G, Kamatireddy G, Walker SE: False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis. J Rheumatol 2001; 28: 2750–2751. [PubMed] [Google Scholar]
  • 13. Kim WJ, Laterza OF, Hock KG, Pierson‐Perry JF, Kaminski DM, et al.: Performance of a revised cardiac troponin method that minimize interferences from heterophilic antibodies. Clin Chem 2002; 48: 1028–1034. [PubMed] [Google Scholar]
  • 14. Paterson D, Beyne P, La Perch T, Logeard D, Bernuau P, et al.: Elevated circulating cardiac troponin in patients with cirrhosis. Hepatology 1999; 29: 640–643. [DOI] [PubMed] [Google Scholar]
  • 15. Guest TM, Ramanthan AV, Tutuer PG, Schechtman KB, Ladenson JH, et al.: Myocardial injury in clinically ill patients: A frequently unrecognized complication. JAMA 1995; 273: 1945–1949. [PubMed] [Google Scholar]
  • 16. Ammann P, Feher T, Minder EI, Gunter C, Bertel O, et al.: Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27: 965–969. [DOI] [PubMed] [Google Scholar]
  • 17. Ammann P, Maggiorini M, Bertel V, Haenseler E, Joller‐Jemelka HI, et al.: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41: 2004–2009. [DOI] [PubMed] [Google Scholar]
  • 18. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, et al.: Myocardial necrosis in ICU patients with acute non‐cardiac disease: a prospective study. Intensive Care Med 2000; 26: 31–37. [DOI] [PubMed] [Google Scholar]
  • 19. Wright RS, Williams B, Crammer H, Gallahue F, Willmore T, et al.: Elevation of cardiac troponin I are associated with increased short‐term mortality in noncardiac critically ill emergency department patients. Am J Cardiol 2002; 90(6): 634–636. [DOI] [PubMed] [Google Scholar]
  • 20. Bakshi TK, Choo MK, Edwards CC, Scott AG, Hart HH, et al.: Causes of elevated troponin I with a normal coronary angiogram. Intern Med J 2002; 32: 520–525. [DOI] [PubMed] [Google Scholar]
  • 21. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S: Elevated troponin levels in absence of coronary artery disease after supraventicular tachycardia. Swiss Med Wkly 2003; 133: 439–441. [DOI] [PubMed] [Google Scholar]
  • 22. Roongsritong C, Warraich I, Bradley C: Common causes of troponin elevation in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004; 125: 1877–1884. [DOI] [PubMed] [Google Scholar]
  • 23. Muller‐Bardorff M, Weidtmann B, Giannitsis E, Kurowski V, Katus HA, et al.: Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem 2002; 48: 673–675. [PubMed] [Google Scholar]
  • 24. Giannitsis E, Muller‐Bardorff M, Kurowski V, Weidtmann B, Wiegnad U, et al.: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211–217. [DOI] [PubMed] [Google Scholar]
  • 25. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, et al.: Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 346–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Binder L, Pieske B, Olschewski, Geibel A, Klosterman B, et al.: N‐terminal pro‐brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112: 1573–1579. [DOI] [PubMed] [Google Scholar]
  • 27. Schaper J, Froede R, Hein S, Buck A, Hashizume H, et al.: Impairment of the myocardial ultrastructure and change of the cytoskeleton in dilated cardiomyopathy. Circulation 1991; 83: 504–514. [DOI] [PubMed] [Google Scholar]
  • 28. Missov E, Calzolaric C, Pau B: Circulating cardiac troponin I in sever congestive heart failure. Circulation 1997; 96: 2953–2958. [DOI] [PubMed] [Google Scholar]
  • 29. La Vecchia L, Mezzena G, Ometto R, Finocchi G, Bedogani F, et al.: Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 1997; 80: 88–90. [PubMed] [Google Scholar]
  • 30. La Vecchia L, Mezzena G, Zanolla L, Ometto R, Finocchi G, et al.: Cardiac troponin I as diagnostic and prognostic marker in sever heart failure. J Heart Lung Transplant 2000; 19: 644–652. [DOI] [PubMed] [Google Scholar]
  • 31. Lund M, French JK, Johnson RN, Williams BF, White HD, et al.: Serum troponin T and I after elective cardioversion. Eur Heart J 2000; 21: 245–253. [DOI] [PubMed] [Google Scholar]
  • 32. Rao AC, Naeen N, John C, Collinson PO, Canepa‐Anson R, et al.: Direct current cardioversion does not cause cardiac damage evidence from cardiac troponin T estimation. Heart 1998; 80: 229–230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Allan JT, Feld RD, Russell AA, Landenson JH, Rogers MA, et al.: Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997; 30: 1052–1056. [DOI] [PubMed] [Google Scholar]
  • 34. Bonnefoy E, Chevalier P, Kirkorian G, Guidolet J, Marchand A, et al.: Cardiac troponin I does not increase after cardiac cardioversion. Chest 1997; 111: 15–18. [DOI] [PubMed] [Google Scholar]
  • 35. Mulner M, Hirsch MM, Herkner H, Sterz F, Leitha T, et al.: Creatine kinase‐MB fraction and cardiac troponin T to diagnose acute myocardial infarction after cardiopulmonary resuscitation. J Am Coll Cardiol 1996; 28: 1220–1225. [DOI] [PubMed] [Google Scholar]
  • 36. Grubb NR, Fox KA, Cawood P: Resucition from out‐of‐hospital cardiac arrest: Implication for cardiac enzyme estimation. Resuscitation 1996; 33: 35–41. [DOI] [PubMed] [Google Scholar]
  • 37. Ver Elst KM, Spapen HD, Neguyen DN, Garbar C, Huyghen LP, et al.: Cardiac troponin T and I are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46: 650–657. [PubMed] [Google Scholar]
  • 38. Tung P, Kopeinik A, Banki N, Ong K, Lawton NT, et al.: Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004; 35: 548–551. [DOI] [PubMed] [Google Scholar]
  • 39. Homma S, Grahame‐Clark C: Editorial comment: Myocardial damage in patients with subarachnoid hemorrhage. Stroke 2004; 35: 552. [DOI] [PubMed] [Google Scholar]
  • 40. DeFilippi C, Waserman S, Rosanio S, Tiblier E, Sperger H, et al.: Cardiac troponin T and C‐reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long‐term hemodialysis. JAMA 2003; 290: 353–359. [DOI] [PubMed] [Google Scholar]
  • 41. Apple FS, Murakami MM, Pearce LA, Herog CA: Predictive value of cardiac troponin I and T for subsequent death in end‐stage renal disease. Circulation 2002; 106: 2941–2945. [DOI] [PubMed] [Google Scholar]
  • 42. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS: Cardiac troponin in renal insufficiency: Review and clinical implications. J Am Col Cardiol 2002; 40: 2065–2071. [DOI] [PubMed] [Google Scholar]
  • 43. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, et al.: Troponin T levels in patients with acute coronary syndrome with or without renal dysfunction. N Eng J Med 2002; 346: 2047–2052. [DOI] [PubMed] [Google Scholar]
  • 44. Apple FS, MuraKami MA, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in end‐stage renal disease. Circulation 2002; 106: 2941–2945. [DOI] [PubMed] [Google Scholar]
  • 45. Ooi DS, Zimmerman D, Graham J, Wells GA: Cardiac troponin T predicts long‐term outcomes in hemodialysis patients. Clin Chem 2001; 47: 412–417. [PubMed] [Google Scholar]
  • 46. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Le Courvoisier C, et al.: Factor associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001; 16: 1452–1458. [DOI] [PubMed] [Google Scholar]
  • 47. Bonnetoy E, Godon P, Kirokorian G, Fatemi P, Chavalier P, et al.: Serum cardiac troponin I and ST‐segment elevation in patients with acute pericarditis Eur Heart J 2000; 21: 832–836. [DOI] [PubMed] [Google Scholar]
  • 48. Brandt RR, Filzmaier K, Hanrath P: Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001; 87: 1326–1328. [DOI] [PubMed] [Google Scholar]
  • 49. Hojs R, Ekhart R, Ho S, Fabjan T, Balon BP, et al.: Cardiac troponin T (cTnT) in hemodialysis patients with asymptomatic and symptomatic artherosclosis. Arch Med Res 2005; 36: 367–371. [DOI] [PubMed] [Google Scholar]
  • 50. Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, et al.: Prog‐ nostic value of serum cardiac troponin I and troponin T chroninc dialysis patients: A 1 year outcomes analysis. Am J Kidney Dis 1997; 29: 399–403. [DOI] [PubMed] [Google Scholar]
  • 51. Ooi DS, Veinot JP, Wells GA, House AA: Increased mortality in hemodialysis patients with elevated serum troponin T: A one‐year outcome study. Clin Biochem 1999; 32: 647–652. [DOI] [PubMed] [Google Scholar]
  • 52. Willing S, Keller F, Steinbach G: Specificty of cardiac troponins I and T in renal disease. Clin Chem Labs Med 1998; 36: 87–92. [DOI] [PubMed] [Google Scholar]
  • 53. Jeremias A, Gibson CM: Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005; 142(a): 786–791. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES